ABSTRACT
In other centers, these risks are higher, including risk of neonatal death from rupture up to 10%–25%.
• Compared with PRCD, TOLAC is associated with slightly higher rates of adverse perinatal outcome: cord pH <7.00 (1.5/1000 TOLAC), HIE (5-8/10,000 TOLAC), and perinatal death (13/10,000 with TOLAC vs. 1/10,000 for PRCD) (Table 14.3). The overall risk of adverse perinatal outcome is 1/2000 with TOLAC, slightly higher than with PRCD.
